Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia

Journal of Microencapsulation

Volumn 28, Issue 8, 2011, Pages 729-742

  Yadav, Khushwant S ^a   Jacob, Sheeba ^b   Sachdeva, Geetanjali ^b   Chuttani, Krishna ^c   Mishra, Anil K ^c   Sawant, Krutika K ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^c INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Biodistribution; Bone; Brain; Cellular uptake; Cytarabine; Long circulating; PEGylated PLGA nanoparticles

Indexed keywords

CYTARABINE; NANOPARTICLE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE; BRAIN; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; FLOW CYTOMETRY; HEART; IC 50; IN VITRO STUDY; INTESTINE; KIDNEY; LEUKEMIA; LIVER; LUNG; MALE; MOUSE; MUSCLE; NONHUMAN; PARTICLE SIZE; RAT; SCANNING ELECTRON MICROSCOPY; SPLEEN; STOMACH; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CYTARABINE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LACTIC ACID; LEUKEMIA; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 82255166883     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.615949     Document Type: Article

References (37)

1. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Livaniou E, Evangelatos G, Ithakissios DS. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm, 2003;259:115-27. (Pubitemid 36638559)
2. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: The state of the art. Critical Rev Therapeutic Drug Carrier Syst, 2004; 21:387-422. (Pubitemid 41647578)
3. Banerjee T, Singh AK, Sharma RK, Maitra AN. Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: Interference by colloidal tin oxide particles. Int J Pharm, 2005;289:189-95. (Pubitemid 40093553)
4. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Delivery Rev, 2002;54:631-51. (Pubitemid 35247520)
5. Cole SP. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemoth Pharm, 1986;17:259-63. (Pubitemid 16070936)
6. Couvreur P, Dubernet C, Puisieux F. Controlled drug delivery with nano-particles: Current possibilities and future trend. Eur J Pharm Biopharm, 1995;41:2-13.
7. Goppert TM, Muller RH. Plasma protein adsorption of tween 80 and polox-amer 188 stabilized solid lipid nanoparticles. J Drug Target, 2003;11(4):225-31. (Pubitemid 37361968)
8. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchillin V, Langer R. Biodegradable long circulating polymeric nanospheres. Science, 1994;263:1600-3. (Pubitemid 24128361)
9. Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urologic Oncology: Seminars and Original Investigations, 2008;26:57-64.
10. Ho DHW, Frei E. Clinical pharmacology of 1-B-D arabinofuranosylcyto-sine. Clin Pharmacol Ther, 1971;12:944-54.
11. Hocking RR. Analysis and selection of variables in linear regression. Biometrics, 1976;32:1-49.
12. Illum L, Davis SS. The organ uplakc of Intravenously administered colloidal particles can be altered using a non-ionic surfactant (poloxamer 338). FEBS Lett, 1984;167:79-82. (Pubitemid 14198834)
13. Konan YN, Cerny R, Favet J, Berton M, Gurny R, Allemann E. Preparation and characterization of sterile sub-200nm meso-tetra(4-hydroxylphe-nyl) porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm, 2003;55(1):115-24. (Pubitemid 36120503)
14. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 1983;15:25-35. (Pubitemid 13092121)
15. Lamprecht A, Ubrich N, Hombreiro PM, Lehr CM, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm, 2000;196:177-82. (Pubitemid 30105738)
16. Levy MY, Benita S. Drug release from submicronized o/w emulsion: A new in vitro kinetic evaluation model. Int J Pharm, 1990;66:29-37.
17. Mehta AK, Yadav KS, Sawant KK. Nimodipine loaded PLGA nanoparticles: Formulation optimization using factorial design, characterization and in vitro evaluation. Curr Drug Del, 2007;4(3):185-93. (Pubitemid 47025402)
18. Mishra PR, Jain NK. Folate conjugated doxorubicin-loaded membrane vesicles for improved cancer therapy. Drug Del, 2003;10:277-82. (Pubitemid 37494142)
19. Moghimi SM, Davis SS. Innovations in avoiding particle clearance from blood by Kupffer cells: Some cause for reflection. Critical Rev Therapeutic Drug Carrier Syst, 1994;11:31-59.
20. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev, 2001;53:283-318. (Pubitemid 32476118)
21. Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Ithakissios DS, Avgoustakis K. Effect of dose on the biodistribution and pharmacokinet-ics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm, 2001;221:143-52. (Pubitemid 32524042)
22. Panyam J, Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol Pharm, 2004;1:77-84.
23. Park W, Kim K, Bae B, Kim Y, Na K. Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur J Pharm Sci, 2010;40(2010):367-75.
24. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60:110-11.
25. Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm Res, 2004;21:354-64. (Pubitemid 38221983)
26. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RR. Etoposide incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies. AAPS J, 2004;6(3):e23.
27. Segawa H, Kimura S, Kuroda J, Sato K, Nogawa M, Yuasa T, Yokota A, Hodohara K, Fujiyama Y, Maekawa T. The anti-leukemic efficacy of the third generation bisphosphonate ONO5920/YM529. Leuk Res, 2005;29:451-7. (Pubitemid 40255820)
28. Soppimath KS, Aminabhavi T, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Controlled Release, 2001;70:1-20. (Pubitemid 32144788)
29. Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AGA, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis SS, et al. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)- poly(ethylene glycol) copolymers. Pharm Res, 1994;11:1800-8. (Pubitemid 24377094)
30. Theobald AE. 1990. Quality control of radiopharmaceuticals. In: Sampson CB, ed. Text book of radiopharmacy: Theory and practice. New York: Gordon and Breach, pp. 127-9.
31. Vandervoort J, Yoncheva K, Ludwig A. Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. Chem Pharma Bull, 2004;52(11):1273-9. (Pubitemid 41364442)
32. Yadav KS, Sawant KK. Modified nanoprecipitation method for preparation of cytarabine loaded PLGA nanoparticles. AAPS Pharm Sci Tech, 2010a;11:1456-65.
33. Yadav KS, Sawant KK. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation. Curr Drug Del, 2010b;7(1):51-64.
34. Yadav KS, Chuttani K, Mishra AK, Sawant KK. Long-circulating nanopar-ticles of etoposide using PLGA-MPEG and PLGA-Pluronic block copol-ymers: Characterization, drug release, blood-clearance, and biodistribution studies. Drug Dev Res, 2010;71:228-39.
35. Yadav KS, Chuttani K, Mishra AK, Sawant KK. Effect of size on biodistribu-tion and blood clearance of etoposide loaded PLGA nanoparticles. PDA J Pharm Sci Tech, 2011;65:131-9.
36. Yoo HS, Park TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release, 2004;100:247-56. (Pubitemid 39491276)
37. Zhang Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-toco-pheryl polyethylene glycol succinate nanoparticles. Biomaterials, 2006;27:4025-33.